MainStay Convertible Investor (MCINX)
The investment objective of MainStay Convertible fund is to provide
capital appreciation and current income. The fund utilizes its assets to
purchase convertible securities such as bonds, debentures, corporate notes, and
preferred stocks or other securities. It may also invest in non-convertible
debt, dividend equity stocks, U.S. government securities, and cash.
Fund Profile
- Fund Inception Date: February 28, 2008
- Ticker Symbol: MCINX
- CUSIP: 56062X526
- Beta (3yr): 1.32
- Rank in category (YTD): 70%
- Category: Convertibles
- Distribution: 1.85%
- Capital Gains: 0%
- Expense Ratio: 1.19%
- Net Assets: $ 710.07 million
- Number of Years Up: 2 years
- Number of Years Down: 1 year
- Effective Duration: 4.2 years
- Annual Turnover Rate: 80%
Updated on 12/2/2012
This balanced fund has year-to-date return of 6.61%. The
5-year annualized return is 3.20%. The best 1-year total return was recorded in
2009 with 42.40%. Based on the load adjusted returns, the fund’s performance is
as follow:
- 1-year: 0.15%
- 3-year: 7.74%
- 5-year: 2.04%
- 10-year: 6.03%
The mutual fund has management fee of 0.25% and front-end
sales load fee of 5.5%. The minimum initial investment is $1,000. You can buy
the mutual fund from 21 brokerages. They are JP Morgan, Scottrade Load, Ing
Financial Advisers – SAS Funds, Raymond James WRAP Eligible, etc. The other
classes of this fund are Class A (MCDAX), Class B (MCSVX), Class C (MCCVX) and
Class Institutional (MCNVX).
The top 5 convertible holdings as of June 2012 are JP Morgan
Chase & Co (3.3%), Apache Corp Preferred (3.2%), Bio Marin Pharmaceuticals
Inc (2.5%), Biovail Corp (2.4%) and Gilead Sciences Inc (2.2%). The top sectors
are Consumer Non-Cyclical (31.6%), Energy (15.0%), Consumer Cyclical (11.9%),
Technology (11.2%) and Communications (10.8%).
According to the fund website, the investment risks are
market risk, convertible securities risk, synthetic convertible securities risk,
debt securities risk, high-yield securities risk, equity securities risk, and foreign
securities risk.
Disclosure: No Position
No comments:
Post a Comment